Young Researcher Award – Danlin Zeng
Danlin Zeng
University of British Columbia, Faculty of Medicine, Vancouver, Canada
Danlin Zeng is an emerging medical researcher affiliated with the University of British Columbia, Faculty of Medicine, Canada. His research activities encompass ophthalmology, pharmacovigilance, clinical outcomes and evidence-based healthcare. His academic profile reflects interdisciplinary research interests and contributions to clinical investigations, with particular relevance to ophthalmic pharmacology and medication-associated ocular adverse events. His work demonstrates engagement with contemporary healthcare research and multidisciplinary scientific collaboration.[1]
1. Abstract
Danlin Zeng’s research profile highlights developing contributions to clinical medicine, ophthalmology and pharmaceutical-related research. His academic activities include investigations into ocular adverse events associated with medications and clinical outcome analysis. His interdisciplinary approach connects pharmacological evidence with patient-centred clinical research. These activities provide a foundation for continued development in ophthalmic pharmacology and translational healthcare research. [2]
2. Keywords
Danlin Zeng, Young Researcher Award, Ophthalmic Pharmacology, Pharmacovigilance, Ocular Adverse Events, Clinical Research, Medication Safety, Ophthalmology, Pharmaceutical Sciences.
3. Introduction
Clinical and pharmaceutical research plays an important role in improving medication safety and healthcare outcomes. Danlin Zeng’s research interests address these areas through clinical investigations, pharmacovigilance and multidisciplinary collaboration. His affiliation with the University of British Columbia provides an academic environment for developing research expertise and contributing to contemporary medical knowledge. [2]
4. Research Profile
Zeng’s documented research activities include ophthalmology, clinical medicine, oncology-related investigations and surgical outcomes. His academic profile identifies experience with statistical analysis, research synthesis and clinical data evaluation. His ophthalmic research includes investigations into medication-associated ocular adverse events, connecting pharmaceutical safety with clinical practice. [2]
5. Research Contributions
His research contributions include collaborative clinical studies and investigations focusing on patient outcomes, medication safety, and evidence-based healthcare. His work encompasses pharmacovigilance research examining ocular adverse events associated with pharmaceutical treatments, clinical investigations evaluating surgical techniques and postoperative outcomes, and interdisciplinary research connecting ophthalmology, oncology, and clinical medicine. These contributions demonstrate his engagement with collaborative clinical research and pharmaceutical safety. [2]
6. Publications
Danlin Zeng’s research contributions include pharmacovigilance analysis of ocular adverse events associated with docetaxel and paclitaxel, clinical research comparing surgical outcomes in laparoscopic procedures, and investigations into the relationship between social isolation, psychological distress, and cancer survival. Additional scholarly work explores dietary approaches to skin cancer prevention and pharmacovigilance-based understanding of dermatological conditions. These publications demonstrate interdisciplinary research interests spanning ophthalmology, oncology, surgery, dermatology, and pharmaceutical safety. [2]
7. Research Impact
His research addresses clinically relevant questions involving medication-associated ocular risks, surgical outcomes and patient health. Such investigations can contribute to the scientific understanding of treatment safety and clinical decision-making. His developing publication record and collaborative research experience indicate continuing academic engagement. Scopus metrics should be interpreted as a profile snapshot rather than a complete measure of research contributions.[1]
8. Award Suitability
Danlin Zeng’s interdisciplinary research activities, emerging publication record and contributions to clinical and pharmaceutical research provide relevant considerations for the Young Researcher Award. His work in ophthalmic pharmacovigilance demonstrates alignment with medication safety and ophthalmic pharmacology. Recognition should consider publication quality, individual research contributions, methodological rigour and future research potential. [1]
9. Conclusion
Danlin Zeng represents an emerging researcher working across clinical medicine, ophthalmology and pharmaceutical-related investigations. His collaborative publications and research interests demonstrate developing academic potential. His continued engagement in evidence-based clinical and pharmacological research may contribute to future developments in healthcare and medication safety.
10. External Links
11. References
- Elsevier. (2026). Scopus author details: Danlin Zeng, Author ID 60739215100. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=60739215100
- International Top Pharmaceutical Awards. (n.d.). Official website and pharmaceutical research awards information. International Top Pharmaceutical Awards.
https://toppharmaceutical.org/
- Sagorin, Z., Zeng, D., Nguyen, N., Yorke, E., & Sampath, S. (2026). Intracorporeal anastomosis versus extracorporeal anastomosis for laparoscopic right hemicolectomy: short-term and long-term outcomes. Surgical Endoscopy. DOI: 10.1007/s00464-026-13128-2.
PubMed publication record